4.6 Editorial Material

Home monitoring for patients with ILD during the COVID-19 pandemic and beyond

Journal

LANCET RESPIRATORY MEDICINE
Volume 8, Issue 12, Pages 1172-1174

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/S2213-2600(20)30452-5

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Respiratory System

Exhaled breath analysis by use of eNose technology: a novel diagnostic tool for interstitial Lung disease

Catharina C. Moor, Judith C. Oppenheimer, Gizal Nakshbandi, Joachim G. J. V. Aerts, Paul Brinkman, Anke-Hilse Maitland-van der Zee, Marlies S. Wijsenbeek

Summary: Exhaled breath analysis using eNose technology shows promising results in accurately distinguishing between ILD patients and healthy controls, as well as different ILD subgroups. This noninvasive diagnostic tool could potentially be a novel biomarker for timely diagnosis in the future.

EUROPEAN RESPIRATORY JOURNAL (2021)

Article Rheumatology

Feasibility of online home spirometry in systemic sclerosis associated interstitial lung disease: a pilot study

Catharina C. Moor, Sander van Leuven, Marlies S. Wijsenbeek, Madelon C. Vonk

Summary: The study aimed to evaluate the feasibility and optimal frequency of online home spirometry in patients with SSc-ILD. Ten patients participated in the study, showing high adherence and satisfaction with the home monitoring application and spirometer. Larger long-term studies are needed to further assess the potential of home spirometry in detecting ILD progression in SSc patients.

RHEUMATOLOGY (2021)

Article Medicine, Research & Experimental

Disease Behaviour During the Peri-Diagnostic Period in Patients with Suspected Interstitial Lung Disease: The STARLINER Study

Marlies S. Wijsenbeek, Elisabeth Bendstrup, Claudia Valenzuela, Michael T. Henry, Catharina C. Moor, Stephane Jouneau, Alessandro G. Fois, Onofre Moran-Mendoza, Syed Anees, Mirela Mirt, Monica Bengus, Frank Gilberg, Klaus-Uwe Kirchgaessler, Carlo Vancheri

Summary: STARLINER aimed to characterize disease behavior in patients with suspected ILD during the peri-diagnostic period using real-time home-based assessments. Despite home spirometry being feasible for most patients and centers, technical and analytical challenges in the home-based assessments prevented firm conclusions regarding disease behavior. Further optimization of the technology and analysis methods is required before widespread implementation.

ADVANCES IN THERAPY (2021)

Review Respiratory System

COVID-19 infection in patients with sarcoidosis: susceptibility and clinical outcomes

Vivienne Kahlmann, Michael Manansala, Catharina C. Moor, Shiva Shahrara, Marlies S. Wijsenbeek, Nadera J. Sweiss

Summary: Patients with sarcoidosis, especially those with moderate to severe impaired pulmonary function, may be at higher risk of adverse outcomes and mortality from COVID-19. The impact of immunosuppressive medication on COVID-19 severity and vaccination response remains unclear. Novel approaches like telemedicine and home monitoring programs show promise for ensuring continuity of care for these patients during the pandemic. Further research specifically focusing on the sarcoidosis population is needed to better understand the risk and clinical outcomes of COVID-19 infection.

CURRENT OPINION IN PULMONARY MEDICINE (2021)

Letter Respiratory System

The use of online visual analogue scales in idiopathic pulmonary fibrosis

Catharina C. Moor, Remy L. M. Mostard, Jan C. Grutters, Paul Bresser, Marlies S. Wijsenbeek

EUROPEAN RESPIRATORY JOURNAL (2022)

Letter Respiratory System

Comparison of the treatment guidelines for sarcoidosis: common sense in the search for evidence

Vivienne Kahlmann, Catharina C. Moor, Jelle R. Miedema, Marlies S. Wijsenbeek

EUROPEAN RESPIRATORY JOURNAL (2022)

Article Medicine, General & Internal

Management of Acute Exacerbation of Idiopathic Pulmonary Fibrosis in Specialised and Non-specialised ILD Centres Around the World

Markus Polke, Yasuhiro Kondoh, Marlies Wijsenbeek, Vincent Cottin, Simon L. F. Walsh, Harold R. Collard, Nazia Chaudhuri, Sergey Avdeev, Juergen Behr, Gregory Calligaro, Tamera J. Corte, Kevin Flaherty, Manuela Funke-Chambour, Martin Kolb, Johannes Krisam, Toby M. Maher, Maria Molina Molina, Antonio Morais, Catharina C. Moor, Julie Morisset, Carlos Pereira, Silvia Quadrelli, Moises Selman, Argyrios Tzouvelekis, Claudia Valenzuela, Carlo Vancheri, Vanesa Vicens-Zygmunt, Julia Waelscher, Wim Wuyts, Elisabeth Bendstrup, Michael Kreuter

Summary: Specialized and non-specialized ILD centers show similarities in approaches to prevention, diagnosis, and treatment of AE-IPF, yet significant differences exist in certain management strategies. Clinical trials and guidelines are necessary to enhance patient care and prognosis in AE-IPF.

FRONTIERS IN MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Diagnostic performance of electronic nose technology in chronic lung allograft dysfunction

Nynke Wijbenga, Rogier A. S. Hoek, Bas J. Mathot, Leonard Seghers, Catharina C. Moor, Joachim G. J. V. Aerts, Daniel Bos, Olivier C. Manintveld, Merel E. Hellemons

Summary: Exhaled breath analysis using an electronic nose (eNose) is a promising novel biomarker for the diagnosis and phenotyping of chronic lung allograft dysfunction (CLAD). eNose technology could be a valuable addition to the diagnostic armamentarium for suspected graft failure in lung transplant recipients (LTR).

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

Article Biochemical Research Methods

Evaluation of different classification methods using electronic nose data to diagnose sarcoidosis

Iris G. van der Sar, Nynke van Jaarsveld, Imme A. Spiekerman, Floor J. Toxopeus, Quint L. Langens, Marlies S. Wijsenbeek, Justin Dauwels, Catharina C. Moor

Summary: Electronic nose technology uses artificial intelligence to classify human breath patterns for diagnostic purposes in medical conditions. This study aims to evaluate different dimensionality reduction methods and classifiers in order to create an accurate diagnostic model for sarcoidosis using electronic nose data.

JOURNAL OF BREATH RESEARCH (2023)

Article Respiratory System

Patient reported side-effects of prednisone and methotrexate in a real-world sarcoidosis population

Vivienne Kahlmann, Catharina C. Moor, Marcel Veltkamp, Marlies S. Wijsenbeek

Summary: The study found that methotrexate has fewer and less bothersome side-effects in treating pulmonary sarcoidosis compared to prednisone. These results need to be confirmed in a larger prospective study.

CHRONIC RESPIRATORY DISEASE (2021)

Review Respiratory System

The smell of lung disease: a review of the current status of electronic nose technology

I. G. van der Sar, N. Wijbenga, G. Nakshbandi, J. G. J. V. Aerts, O. C. Manintveld, M. S. Wijsenbeek, M. E. Hellemons, C. C. Moor

Summary: There is a potential for electronic nose (eNose) technology to be used in diagnosis of lung diseases, but current research suffers from heterogeneity in study design and differences between eNose devices, hampering generalization and comparison of results.

RESPIRATORY RESEARCH (2021)

Article Respiratory System

The Value of the Surprise Question to Predict One-Year Mortality in Idiopathic Pulmonary Fibrosis: A Prospective Cohort Study

Catharina C. Moor, Nelleke C. Tak van Jaarsveld, Catherine Owusuaa, Jelle R. Miedema, Sara Baart, Carin C. D. van der Rijt, Marlies S. Wijsenbeek

Summary: The study evaluated the predictive value of the surprise question for 1-year mortality in IPF and found that the question can accurately predict 1-year mortality, assisting in the timely initiation of palliative care for patients with IPF.

RESPIRATION (2021)

Review Respiratory System

Educational aspects of rare and orphan lung diseases

Tiago M. Alfaro, Marlies S. Wijsenbeek, Pippa Powell, Daiana Stolz, John R. Hurst, Michael Kreuter, Catharina C. Moor

Summary: People with rare lung diseases often face delayed diagnosis, limited treatment options, and difficulty in finding expert physicians. The limited education and training for healthcare practitioners on rare diseases contribute to the delay in diagnosis. Patients and families seek easier access to high-quality education materials to manage their own diseases. Increased awareness and development of patient-centered international expert networks are essential for improving care and education on rare lung diseases.

RESPIRATORY RESEARCH (2021)

Article Respiratory System

Patient expectations, experiences and satisfaction with nintedanib and pirfenidone in idiopathic pulmonary fibrosis: a quantitative study

C. C. Moor, R. L. M. Mostard, J. C. Grutters, P. Bresser, J. G. J. Aerts, C. D. Dirksen, M. L. Kimman, M. S. Wijsenbeek

RESPIRATORY RESEARCH (2020)

Letter Respiratory System

The world is not enough - the value of increasing registry data in idiopathic pulmonary fibrosis

C. C. Moor, M. Kreuter, F. Luppi, W. A. Wuyts

RESPIRATORY RESEARCH (2020)

No Data Available